Medicare Enrolled
Dr. Saman Moazami, M.D.
Urology Physician · Rockaway, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moazami from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moazami?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moazami
Dr. Saman Moazami is an urology physician in Rockaway, NJ, with 14 years of NPI registration. Based on federal Medicare data, Dr. Moazami performed 2,028 Medicare services across 1,369 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moazami received a total of $9,810 from 61 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moazami is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ 2,028 Medicare services
$9,810 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,028
Medicare services
Bottom 40% in NJ for urology physician
1,369
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
705 | $102 | $420 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
522 | $2 | $7 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
305 | $10 | $54 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $136 | $556 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $75 | $291 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
66 | $202 | $782 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
51 | $55 | $224 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $73 | $293 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
18 | $13 | $322 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $42 | $187 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
17 | $140 | $10,991 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $110 | $2,072 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $148 | $593 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $68 | $257 |
| Complicated insertion of bladder tube | 14 | $128 | $504 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
13 | $116 | $1,626 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
13 | $21 | $395 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
11 | $10 | $151 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $118 | $555 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
11 | $111 | $430 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
18.7% medium
80.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,810
Total received (2018-2024)
Avg $1,401/year across 7 years
Top 14% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,786 (89.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$670 (6.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$354 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,034
2023
$1,366
2022
$2,059
2021
$1,601
2020
$544
2019
$993
2018
$1,214
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$906
IMMUNITYBIO, INC.
$153
Medtronic, Inc.
$136
Sumitomo Pharma America, Inc.
$135
ABBVIE INC.
$124
Janssen Biotech, Inc.
$88
Ferring Pharmaceuticals Inc.
$67
Telix Pharmaceuticals
$66
180 Medical, Inc.
$53
Becton, Dickinson and Company
$48
UROGEN PHARMA, INC.
$47
Bayer Healthcare Pharmaceuticals Inc.
$42
Merck Sharp & Dohme LLC
$34
AstraZeneca Pharmaceuticals LP
$34
Cook Medical LLC
$19
Boston Scientific Corporation
$17
Laborie Medical Technologies Corp.
$17
Endo USA, Inc.
$16
Antares Pharma, Inc.
$16
Blue Earth Diagnostics Limited
$16
Top 3 companies account for 58.8% of 2024 payments
All-time payments by company (2018-2024) ›
PROCEPT BioRobotics Corporation
$1,342
Teleflex LLC
$925
Coloplast Corp
$889
C. R. Bard, Inc. & Subsidiaries
$670
Astellas Pharma US Inc
$533
Sumitomo Pharma America, Inc.
$306
Endo Pharmaceuticals Inc.
$278
NeoTract Inc.
$269
COLOPLAST CORP
$250
Allergan Inc.
$245
ABBVIE INC.
$223
Janssen Biotech, Inc.
$206
180 Medical, Inc.
$179
Myriad Genetic Laboratories, Inc.
$177
UROVANT SCIENCES INC
$174
Merck Sharp & Dohme Corporation
$168
Medtronic, Inc.
$163
IMMUNITYBIO, INC.
$153
Progenics Pharmaceuticals, Inc.
$143
Davol Inc.
$133
AstraZeneca Pharmaceuticals LP
$124
Axonics, Inc.
$123
PFIZER INC.
$122
Merck Sharp & Dohme LLC
$118
Allergan, Inc.
$116
Bayer HealthCare Pharmaceuticals Inc.
$113
Cook Medical LLC
$109
Medtronic USA, Inc.
$95
Axonics Modulation Technologies, Inc.
$87
Boston Scientific Corporation
$86
Ferring Pharmaceuticals Inc.
$82
Telix Pharmaceuticals
$81
Myovant Sciences Inc.
$79
Hollister Incorporated
$72
Blue Earth Diagnostics Limited
$70
Ethicon US, LLC
$66
Bayer Healthcare Pharmaceuticals Inc.
$65
Dendreon Pharmaceuticals LLC
$64
TOLMAR Pharmaceuticals, Inc.
$57
Antares Pharma, Inc.
$56
Agiliti Surgical, Inc.
$52
Tolmar, Inc.
$49
Becton, Dickinson and Company
$48
Palette Life Sciences, Inc.
$48
UROGEN PHARMA, INC.
$47
Retrophin, Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$29
Clarus Therapeutics Inc.
$29
AbbVie, Inc.
$29
Avadel Specialty Pharmaceuticals, LLC
$27
Amgen Inc.
$26
Metuchen Pharmaceuticals
$26
AbbVie Inc.
$23
Olympus America Inc.
$21
Medtronic Vascular, Inc.
$21
Ambu Inc.
$18
Laborie Medical Technologies Corp.
$17
Endo USA, Inc.
$16
DENTSPLY IH AB
$15
UroGen Pharma, Inc.
$15
GENZYME CORPORATION
$12
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 3F · ADSTILADRIN · AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BOTOX · BPH · COOK · COOK MEDICAL DILATION/ACCESS · Channel Drain · Dormia · EDEX · ELIGARD · ERLEADA · GEMTESA · General - Erectile Dysfunction · ILLUCCIX · INTERSTIM · Isiris · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ONLI · ORGOVYX · OTREXUP · Onli · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · PreciseTumor · Progel · Prolaris · REZUM · SPACEOAR VUE · SURGIFLO Hemostatic Matrix Family of Products · Sonablate · Stendra · TITAN · Titan · UroLift · UroLift System · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
146
Per 100K population
28.6
County median income
$134,929
Nearest hospital
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moazami is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of NJ peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moazami experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Moazami performed 705 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moazami receive payments from pharmaceutical companies?
Yes. Dr. Moazami received a total of $9,810 from 61 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moazami's costs compare to other urology physicians in Rockaway?
Dr. Moazami's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moazami) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rockaway
Browse urology physicians in Rockaway ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology